isplicer, you say:
"Everyone's views should be respected, but it all simply comes down to how the trial results go. You can post all the analyst valuations in the world and argue with downrampers till the cows come home, but in the end you're just betting on the outcome of CVac. Personally, I haven't spoken with any company members and haven't looked into the technology, so I have NO WAY of knowing what the probability of success is. And thus I would never touch PRR."
Yes everyones views should be respected, and you are right about the trial results. Did you notice Boilers comments regarding CANVAS trials being approved to commence months before results of Ph IIb are released? Your a smart guy so Im sure you can put 2 and 2 together!
Interesting debate guys, thanks to all contributors!
analyst valuations, page-81
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.020(6.67%) |
Mkt cap ! $464.8M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 32.3¢ | 30.0¢ | $1.040M | 3.328M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 42705 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |